At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 85 enrolled
Drug / intervention
BI 730357 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Partially-blind, Randomized, Parallel Group, Placebo and Active Comparator-controlled Phase I Clinical Trial to Evaluate the Photosensitivity Potential of BI 730357
In Brief
A Phase 1 clinical trial evaluating BI 730357, Placebo to match BI 730357, and 1 other intervention for Healthy. Completed, enrolled 85 participants across 1 site.
Detailed Summary
To evaluate the photosensitivity potential of BI 730357
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2020202120222023202420252026
First PostedNov 2019
Enrollment StartNov 2019
Primary CompletionSep 2020
TodayJul 2026
First PostedNov 1, 2019
Enrollment StartNov 6, 2019
Primary CompletionSep 9, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 6.7 years ago
Interventions
BI 730357drug
Film-coated tablet
Placebo to match BI 730357drug
Film-coated tablet
Ciprofloxacindrug
Film-coated tablet